Complix wins €1.9m grant to advance CPABs development
The Flanders government has awarded the grant through the agency for innovation by science and technology, IWT. Complix CEO Dr Mark Vaeck said the results generated so far
SK bioscience is set to lead the Gates Foundation-fundedResearch Optimization & Trial Outcome Recommender (ROTOR) project, an AI-based platform aimed at reducing uncertainty in vaccine-development decisions.